SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-225163
Filing Date
2005-11-14
Accepted
2005-11-14 11:54:02
Documents
7
Period of Report
2005-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K d8k.htm 8-K 22291
2 EMPLOYMENT AGREEMENT dex101.htm EX-10.1 38197
3 SEVERENCE LETTER AGREEMENT dex102.htm EX-10.2 27446
4 FORM OF A STOCK OPTION AGREEMENT dex103.htm EX-10.3 46516
5 FORM OF A RESTRICTED STOCK AGREEMENT dex104.htm EX-10.4 31468
6 PRESS RELEASE dex991.htm EX-99.1 12103
7 GRAPHIC g44366img001.jpg GRAPHIC 22954
  Complete submission text file 0001193125-05-225163.txt   211324
Mailing Address 352 KNOTTER DRIVE CHESHIRE CT 06511
Business Address 352 KNOTTER DRIVE CHESHIRE CT 06511 2037761790
ALEXION PHARMACEUTICALS INC (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 051197946
SIC: 2834 Pharmaceutical Preparations